Jerome C. Foo , Maja P. Völker , Fabian Streit , Josef Frank , Norman Zacharias , Lea Zillich , Lea Sirignano , Peter Nürnberg , Thomas F. Wienker , Michael Wagner , Markus M. Nöthen , Michael Nothnagel , Henrik Walter , Bernd Lenz , Rainer Spanagel , Falk Kiefer , Georg Winterer , Marcella Rietschel , Stephanie H. Witt
{"title":"尼古丁使用的多基因风险评分和吸烟家族史与吸烟行为有关","authors":"Jerome C. Foo , Maja P. Völker , Fabian Streit , Josef Frank , Norman Zacharias , Lea Zillich , Lea Sirignano , Peter Nürnberg , Thomas F. Wienker , Michael Wagner , Markus M. Nöthen , Michael Nothnagel , Henrik Walter , Bernd Lenz , Rainer Spanagel , Falk Kiefer , Georg Winterer , Marcella Rietschel , Stephanie H. Witt","doi":"10.1016/j.drugalcdep.2024.112415","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Formal genetics studies show that smoking is influenced by genetic factors; exploring this on the molecular level can offer deeper insight into the etiology of smoking behaviours.</p></div><div><h3>Methods</h3><p>Summary statistics from the latest wave of the GWAS and Sequencing Consortium of Alcohol and Nicotine (GSCAN) were used to calculate polygenic risk scores (PRS) in a sample of ~2200 individuals who smoke/individuals who never smoked. The associations of smoking status with PRS for Smoking Initiation (i.e., Lifetime Smoking; SI-PRS), and Fagerström Test for Nicotine Dependence (FTND) score with PRS for Cigarettes per Day (CpD-PRS) were examined, as were distinct/additive effects of parental smoking on smoking status.</p></div><div><h3>Results</h3><p>SI-PRS explained 10.56% of variance (Nagelkerke-R<sup>2</sup>) in smoking status (p=6.45x10<sup><em>−</em>30</sup>). In individuals who smoke, CpD-PRS was associated with FTND score (R<sup>2</sup>=5.03%, p=1.88x10<sup><em>–</em>12</sup>). Parental smoking alone explained R<sup>2</sup>=3.06% (p=2.43×10<sup>−12</sup>) of smoking status, and 0.96% when added to the most informative SI-PRS model (total R²=11.52%).</p></div><div><h3>Conclusion</h3><p>These results show the potential utility of molecular genetic data for research investigating smoking prevention. The fact that PRS explains more variance than family history highlights progress from formal to molecular genetics; the partial overlap and increased predictive value when using both suggests the importance of combining these approaches.</p></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"263 ","pages":"Article 112415"},"PeriodicalIF":3.9000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0376871624013401/pdfft?md5=07785b4116088d737363aea286342ea5&pid=1-s2.0-S0376871624013401-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Polygenic risk scores for nicotine use and family history of smoking are associated with smoking behaviour\",\"authors\":\"Jerome C. Foo , Maja P. Völker , Fabian Streit , Josef Frank , Norman Zacharias , Lea Zillich , Lea Sirignano , Peter Nürnberg , Thomas F. Wienker , Michael Wagner , Markus M. Nöthen , Michael Nothnagel , Henrik Walter , Bernd Lenz , Rainer Spanagel , Falk Kiefer , Georg Winterer , Marcella Rietschel , Stephanie H. Witt\",\"doi\":\"10.1016/j.drugalcdep.2024.112415\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Formal genetics studies show that smoking is influenced by genetic factors; exploring this on the molecular level can offer deeper insight into the etiology of smoking behaviours.</p></div><div><h3>Methods</h3><p>Summary statistics from the latest wave of the GWAS and Sequencing Consortium of Alcohol and Nicotine (GSCAN) were used to calculate polygenic risk scores (PRS) in a sample of ~2200 individuals who smoke/individuals who never smoked. The associations of smoking status with PRS for Smoking Initiation (i.e., Lifetime Smoking; SI-PRS), and Fagerström Test for Nicotine Dependence (FTND) score with PRS for Cigarettes per Day (CpD-PRS) were examined, as were distinct/additive effects of parental smoking on smoking status.</p></div><div><h3>Results</h3><p>SI-PRS explained 10.56% of variance (Nagelkerke-R<sup>2</sup>) in smoking status (p=6.45x10<sup><em>−</em>30</sup>). In individuals who smoke, CpD-PRS was associated with FTND score (R<sup>2</sup>=5.03%, p=1.88x10<sup><em>–</em>12</sup>). Parental smoking alone explained R<sup>2</sup>=3.06% (p=2.43×10<sup>−12</sup>) of smoking status, and 0.96% when added to the most informative SI-PRS model (total R²=11.52%).</p></div><div><h3>Conclusion</h3><p>These results show the potential utility of molecular genetic data for research investigating smoking prevention. The fact that PRS explains more variance than family history highlights progress from formal to molecular genetics; the partial overlap and increased predictive value when using both suggests the importance of combining these approaches.</p></div>\",\"PeriodicalId\":11322,\"journal\":{\"name\":\"Drug and alcohol dependence\",\"volume\":\"263 \",\"pages\":\"Article 112415\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2024-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0376871624013401/pdfft?md5=07785b4116088d737363aea286342ea5&pid=1-s2.0-S0376871624013401-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and alcohol dependence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0376871624013401\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0376871624013401","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Polygenic risk scores for nicotine use and family history of smoking are associated with smoking behaviour
Introduction
Formal genetics studies show that smoking is influenced by genetic factors; exploring this on the molecular level can offer deeper insight into the etiology of smoking behaviours.
Methods
Summary statistics from the latest wave of the GWAS and Sequencing Consortium of Alcohol and Nicotine (GSCAN) were used to calculate polygenic risk scores (PRS) in a sample of ~2200 individuals who smoke/individuals who never smoked. The associations of smoking status with PRS for Smoking Initiation (i.e., Lifetime Smoking; SI-PRS), and Fagerström Test for Nicotine Dependence (FTND) score with PRS for Cigarettes per Day (CpD-PRS) were examined, as were distinct/additive effects of parental smoking on smoking status.
Results
SI-PRS explained 10.56% of variance (Nagelkerke-R2) in smoking status (p=6.45x10−30). In individuals who smoke, CpD-PRS was associated with FTND score (R2=5.03%, p=1.88x10–12). Parental smoking alone explained R2=3.06% (p=2.43×10−12) of smoking status, and 0.96% when added to the most informative SI-PRS model (total R²=11.52%).
Conclusion
These results show the potential utility of molecular genetic data for research investigating smoking prevention. The fact that PRS explains more variance than family history highlights progress from formal to molecular genetics; the partial overlap and increased predictive value when using both suggests the importance of combining these approaches.
期刊介绍:
Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.